The Federal Circuit’s recent decision in United Therapeutics Corp. v. Liquidia Techs., Inc., No. 2022-2217, 2023 WL 4695903 (Fed. Cir. July 24, 2023), provides an interesting discussion on the written ...
Patent offices may reject a patent application with claims reciting using a composition to treat a disease, based on the requirement that the claimed treatment is not fully supported by the ...
The Method as a Whole Was Not Expressly Described Compliance with the written description requirement of Section 112 is a question of fact, judged from the perspective of a skilled artisan as of the ...
Largely relying on DNA barcoding, rather than traditional practices, a simplified diagnostics method for species description could be the key to revealing Earth's biodiversity before much of it goes ...
The aim of this study was to develop, operationalize, and pilot test a transparent, reproducible, and evidence-informed method to determine when to report incidental findings from next-generation ...